Analysis Of Income And Expense [Abstract]

Sopharma AD - Filing #6022427

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	—	—	—	—	—	—	—	—	1,603,310,000 BGN	—	1,438,826,000 BGN	—	—	—	—	—	—	—	—	—	—
Material income and expense [abstract]
Finance income (cost)	—	—	—	—	—	—	—	—	—	5,165,000 BGN	—	14,018,000 BGN	—	—	—	—	—	—	—	—	—	—
Other operating income (expense)	—	—	—	—	—	—	—	—	—	13,830,000 BGN	—	12,677,000 BGN	—	—	—	—	—	—	—	—	—	—
Miscellaneous other operating expense	—	—	—	—	—	—	—	—	—	16,095,000 BGN	—	15,767,000 BGN	—	—	—	—	—	—	—	—	—	—
Expenses by nature [abstract]
Raw materials and consumables used	—	—	—	—	—	—	—	—	—	83,122,000 BGN	—	89,324,000 BGN	—	—	—	—	—	—	—	—	—	—
Services expense	—	—	—	—	—	—	—	—	—	75,927,000 BGN	—	80,869,000 BGN	—	—	—	—	—	—	—	—	—	—
Classes of employee benefits expense [abstract]
Employee benefits expense	—	—	—	—	—	—	—	—	—	150,061,000 BGN	—	133,547,000 BGN	—	—	—	—	—	—	—	—	—	—
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	—	—	—	—	—	—	—	—	—	53,187,000 BGN	—	46,633,000 BGN	—	—	—	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method	—	—	—	—	—	—	—	—	—	12,092,000 BGN	—	5,976,000 BGN	—	—	—	—	—	—	—	—	—	—
Share of other comprehensive income of associates and joint ventures accounted for using equity method, before tax [abstract]
Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, before tax	—	—	—	—	—	—	—	—	—	3,708,000 BGN	—	6,150,000 BGN	—	—	—	—	—	—	—	—	—	—
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss	—	—	—	—	—	—	—	—	—	1,150,000 BGN	—	4,000 BGN	—	—	—	—	—	—	—	—	—	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	1,728,000 BGN	- BGN	- BGN	- BGN	9,485,000 BGN	101,970,000 BGN	3,367,000 BGN	355,000 BGN	- BGN	103,698,000 BGN	89,473,000 BGN	16,773,000 BGN	- BGN	29,614,000 BGN	637,000 BGN	- BGN	37,000 BGN	- BGN	6,763,000 BGN	5,404,000 BGN	22,177,000 BGN	- BGN
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	—	—	—	—	—	—	—	—	101,970,000 BGN	—	22,177,000 BGN	—	—	—	—	—	—	—	—	—	—
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	—	—	—	—	—	—	—	—	—	1,728,000 BGN	—	5,404,000 BGN	—	—	—	—	—	—	—	—	—	—